Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.

Autor: Haggenburg S; Department of Hematology and., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Amsterdam, The Netherlands., van Binnendijk RS; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., den Hartog G; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Bhoekhan MS; Department of Hematology and., Haverkate NJE; Department of Experimental Immunology., de Rooij DM; Department of Experimental Immunology., van Meerloo J; Cancer Center Amsterdam., Cloos J; Cancer Center Amsterdam., Kootstra NA; Department of Experimental Immunology., Wouters D; Department of Clinical Chemistry., Weijers SS; Central Diagnostic Laboratory, and., van Leeuwen EMM; Department of Experimental Immunology.; Laboratory Medical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Bontkes HJ; Laboratory Medical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tonouh-Aajoud S; Laboratory Medical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Heemskerk MHM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Sanders RW; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Roelandse-Koop E; Department of Clinical Chemistry., Hofsink Q; Department of Hematology and., Groen K; Department of Hematology and., Çetinel L; Department of Hematology and., Schellekens L; Department of Hematology and., den Hartog YM; Department of Hematology and., Toussaint B; Department of Hematology and., Kant IMJ; Department of Hematology and., Graas T; Department of Hematology and., de Pater E; Department of Hematology and., Dik WA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Engel MD; Department of Hematology and., Pierie CRN; Department of Hematology and., Janssen SR; Department of Hematology and., van Dijkman E; Department of Hematology and., Poniman M; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Burger JA; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Bouhuijs JH; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Smits G; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Rots NY; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Zweegman S; Department of Hematology and.; Cancer Center Amsterdam., Kater AP; Department of Hematology and.; Cancer Center Amsterdam., van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Mutsaers PGNJ; Department of Hematology and., van Doesum JA; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Broers AEC; Department of Hematology and., van Gils MJ; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands., Goorhuis A; Department of Infectious Diseases, Amsterdam University Medical Center, Amsterdam, The Netherlands; and., Rutten CE; Department of Hematology and., Hazenberg MD; Department of Hematology and.; Cancer Center Amsterdam.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Nijhof IS; Department of Hematology and.; Cancer Center Amsterdam.

Publikováno v: Blood advances [Blood Adv] 2022 Mar 08; Vol. 6 (5), pp. 1537-1546.

IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization.

Autor: Castaño Z; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., San Juan BP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia., Spiegel A; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Pant A; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., DeCristo MJ; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Laszewski T; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Ubellacker JM; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Janssen SR; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Dongre A; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Reinhardt F; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Henderson A; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Del Rio AG; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Gifford AM; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA., Hutchinson JN; Department of Biostatistics, Harvard T.H. Chan, School of Public Health, Boston, MA, USA., Weinberg RA; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.; MIT Department of Biology and Ludwig/MIT Center for Molecular Oncology, Cambridge, MA, USA., Chaffer CL; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. c.chaffer@garvan.org.au.; Whitehead Institute for Biomedical Research, Cambridge, MA, USA. c.chaffer@garvan.org.au., McAllister SS; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. smcallister1@bwh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. smcallister1@bwh.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. smcallister1@bwh.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. smcallister1@bwh.harvard.edu.

Publikováno v: Nature cell biology [Nat Cell Biol] 2018 Sep; Vol. 20 (9), pp. 1084-1097. Date of Electronic Publication: 2018 Aug 27.